Today, the U.S. Supreme Court unanimously invalidated patents on two genes associated with hereditary breast and ovarian cancer in response to a lawsuit filed by the American Civil Liberties Union and the Public Patent Foundation.
This is a huge victory not only for those seeking to have their genes tested in order to make informed medical decisions but for civil liberties, scientific freedom, patients, and the future of personalized medicine.
ACLU Wins Unanimous Decision in Challenge to Gene Patenting
Related Issues
Related content

As AI Gains Power, We Must Push for Guardrails to Protect Civil...
July 2, 2025
Weekly Highlights June 23 - 27
June 28, 2025
Weekly Highlights May 5 - 9
May 9, 2025
Legislature Considering Bill to Protect Mainers’ Privacy, Empower...
May 5, 2025
Weekly Highlights: March 24 - 28
March 27, 2025
Can Border Agents Search Your Electronic Devices? It’s Complicated.
March 25, 2025
Machine Surveillance is Being Super-Charged by Large AI Models
March 21, 2025
Protecting Mainers' Privacy from Big Tech
January 1, 2025